Literature DB >> 8088141

Topical application of artesunate on guinea pig allergic contact dermatitis.

H Chen1, H I Maibach.   

Abstract

Artesunate is derived from the Chinese medicinal herb qinghao. Many animal studies suggest that systemic artesunate has immunoregulatory activity. We investigated the effect of topical artesunate on contact sensitivity in guinea pigs sensitized with DNCB. Female hairless guinea pigs were used and the contact reaction graded by visual (5 point) score and erythema measured with a color analyzer. Topical artesunate inhibited the elicitation reaction of contact hypersensitivity when given at the 1st and 12th h after challenge (p < 0.05), but showed no effect when given from day 3 to day 1 before challenge (p > 0.05). Artesunate had no effect on toxic (irritant) contact dermatitis from 20% croton oil (p > 0.05). The results indicate that topical application of artesunate may offer a novel treatment of allergic contact dermatitis and other cutaneous immune-mediated disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088141     DOI: 10.1111/j.1600-0536.1994.tb00598.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  4 in total

1.  Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.

Authors:  J-X Wang; W Tang; L-P Shi; J Wan; R Zhou; J Ni; Y-F Fu; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

Review 2.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Authors:  S R Meshnick; T E Taylor; S Kamchonwongpaisan
Journal:  Microbiol Rev       Date:  1996-06

3.  Novel Pharmacological Activity of Artesunate and Artemisinin: Their Potential as Anti-Tubercular Agents.

Authors:  Won Hyung Choi
Journal:  J Clin Med       Date:  2017-03-10       Impact factor: 4.241

4.  Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?

Authors:  Tuğçenur Uzun; Orcun Toptas
Journal:  Chin Med       Date:  2020-05-28       Impact factor: 5.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.